David Shaw’s Inspire Medical Systems INSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $65.6M | Buy |
1,470,462
+281,925
| +24% | +$13.4M | 0.03% | 624 |
|
|
2026
Q1 | $61.3M | Sell |
1,188,537
-23,625
| -2% | -$1.65M | 0.04% | 572 |
|
|
2025
Q4 | $112M | Buy |
1,212,162
+853,305
| +238% | +$81.6M | 0.06% | 366 |
|
|
2025
Q3 | $26.6M | Buy |
358,857
+344,635
| +2,423% | +$34.9M | 0.02% | 991 |
|
|
2025
Q2 | $1.85M | Sell |
14,222
-373
| -3% | -$54.1K | ﹤0.01% | 2790 |
|
|
2025
Q1 | $2.32M | Buy |
14,595
+6,842
| +88% | +$1.24M | ﹤0.01% | 2499 |
|
|
2024
Q4 | $1.44M | Buy |
7,753
+4,780
| +161% | +$928K | ﹤0.01% | 2978 |
|
|
2024
Q3 | $627K | Sell |
2,973
-20,310
| -87% | -$3.53M | ﹤0.01% | 3573 |
|
|
2024
Q2 | $3.12M | Sell |
23,283
-8,205
| -26% | -$1.55M | ﹤0.01% | 2236 |
|
|
2024
Q1 | $6.76M | Sell |
31,488
-153,460
| -83% | -$30.1M | 0.01% | 1663 |
|
|
2023
Q4 | $37.6M | Buy |
184,948
+20,246
| +12% | +$3.28M | 0.03% | 588 |
|
|
2023
Q3 | $32.7M | Sell |
164,702
-254,631
| -61% | -$64.2M | 0.03% | 600 |
|
|
2023
Q2 | $136M | Buy |
419,333
+201,915
| +93% | +$57.7M | 0.14% | 162 |
|
|
2023
Q1 | $50.9M | Buy |
217,418
+76,715
| +55% | +$19.4M | 0.05% | 417 |
|
|
2022
Q4 | $35.4M | Buy |
140,703
+43,904
| +45% | +$9.36M | 0.04% | 587 |
|
|
2022
Q3 | $17.2M | Sell |
96,799
-16,265
| -14% | -$3.27M | 0.02% | 951 |
|
|
2022
Q2 | $20.7M | Sell |
113,064
-111,845
| -50% | -$22.3M | 0.02% | 850 |
|
|
2022
Q1 | $57.7M | Sell |
224,909
-47,978
| -18% | -$11M | 0.05% | 424 |
|
|
2021
Q4 | $62.8M | Sell |
272,887
-41,159
| -13% | -$10M | 0.05% | 443 |
|
|
2021
Q3 | $73.1M | Sell |
314,046
-30,497
| -9% | -$6.36M | 0.07% | 362 |
|
|
2021
Q2 | $66.6M | Sell |
344,543
-50,576
| -13% | -$10M | 0.06% | 415 |
|
|
2021
Q1 | $81.8M | Sell |
395,119
-143,567
| -27% | -$30.5M | 0.08% | 302 |
|
|
2020
Q4 | $101M | Sell |
538,686
-32,727
| -6% | -$5.35M | 0.09% | 263 |
|
|
2020
Q3 | $73.7M | Buy |
571,413
+11,730
| +2% | +$1.29M | 0.08% | 301 |
|
|
2020
Q2 | $48.7M | Buy |
559,683
+135,413
| +32% | +$10.4M | 0.06% | 362 |
|
|
2020
Q1 | $25.6M | Buy |
424,270
+63,015
| +17% | +$4.66M | 0.04% | 507 |
|
|
2019
Q4 | $26.8M | Buy |
361,255
+1,055
| +0.3% | +$67.8K | 0.03% | 672 |
|
|
2019
Q3 | $22M | Buy |
360,200
+76,456
| +27% | +$5.03M | 0.03% | 730 |
|
|
2019
Q2 | $17.2M | Sell |
283,744
-3,232
| -1% | -$174K | 0.02% | 827 |
|
|
2019
Q1 | $16.3M | Buy |
286,976
+227,438
| +382% | +$12.3M | 0.02% | 830 |
|
|
2018
Q4 | $2.52M | Buy |
59,538
+26,325
| +79% | +$1.12M | ﹤0.01% | 1963 |
|
|
2018
Q3 | $1.4M | Buy |
+33,213
| New | +$1.56M | ﹤0.01% | 2453 |
|
Other funds holding INSP
SCM
DM
David Shaw's INSP Position: Q2 2026 in Review
David Shaw increased its Inspire Medical Systems (INSP) stake by 24% in Q2 2026, buying an estimated $13.4M and bringing the position to 1,470,462 shares worth $65.6M. The position accounts for 0.03% of the portfolio, ranked #624.
David Shaw first reported a position in INSP in Q3 2018 and has held it in 32 quarters since. The position peaked at $136M in Q2 2023. 274 funds tracked by Wall St. Rank hold INSP as of Q2 2026.
- David Shaw held 1,470,462 shares of Inspire Medical Systems worth $65.6M as of Q2 2026.
- David Shaw bought 281,925 Inspire Medical Systems shares in Q2 2026, an estimated $13.4M.
- Inspire Medical Systems made up 0.03% of David Shaw's portfolio in Q2 2026, its #624 holding.
- David Shaw first reported a position in Inspire Medical Systems in Q3 2018 and has held it in 32 quarters since.
- David Shaw's Inspire Medical Systems position peaked at $136M in Q2 2023.
- 274 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2026.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.